Synthesis and SAR of 99mTc/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates
Graphical abstract
Section snippets
Acknowledgments
We thank Mr. Jeffrey Muddiman for running high resolution mass spectra.
References and notes (31)
- et al.
Coord. Chem. Rev.
(1999) - American Cancer Society, Cancer facts & Figures,...
- et al.
Curr. Oncol. Rep.
(2011) - et al.
Cancers
(2010) - et al.
Curr. Opin. Urol.
(2011) - et al.
Prostate
(2000) - et al.
Cancer Res.
(1997) - et al.
Prostate
(1998) - et al.
Prostate Cancer P. D.
(2002) - et al.
J. Nucl. Med.
(2003)
J. Med. Chem.
(2010)
J. Med. Chem.
(2008)
Eur. J. Nucl. Med. Mol. Imaging
(2007)
BJU Int.
(2007)
J. Nucl. Med.
(2006)
Cited by (76)
Technetium(I) carbonyl complexes for nuclear medicine: Coordination-chemical aspect
2023, Coordination Chemistry ReviewsRecent advancements in <sup>18</sup>F-labeled PSMA targeting PET radiopharmaceuticals
2022, Nuclear Medicine and BiologyIn vitro and in vivo response of PSMA-617 radiolabeled with CA and NCA lutetium-177
2022, Applied Radiation and IsotopesTotal chemical synthesis of PSMA-11: API for <sup>68</sup>Ga-PSMA-11 used for prostate cancer diagnosis
2021, European Journal of Medicinal Chemistry ReportsThe Role of Theranostics in Prostate Cancer
2021, Seminars in Radiation OncologyThe emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy
2021, Nuclear Medicine and Biology
Copyright © 2012 Elsevier Ltd. All rights reserved.